KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers.

Yan M, Liu K, Xu J, Liu Y, Ji L, Zhang S

DOI: 10.1186/s12943-026-02659-w
Published: 2026 Apr 10
Container: Molecular cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-026-02659-w,
  title = {KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers.},
  author = {Yan M and Liu K and Xu J and Liu Y and Ji L and Zhang S},
  year = {2026},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-026-02659-w},
  url = {https://doi.org/10.1186/s12943-026-02659-w}
}

RIS

TY  - JOUR
TI  - KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers.
AU  - Yan M
AU  - Liu K
AU  - Xu J
AU  - Liu Y
AU  - Ji L
AU  - Zhang S
PY  - 2026
JO  - Molecular cancer
DO  - 10.1186/s12943-026-02659-w
UR  - https://doi.org/10.1186/s12943-026-02659-w
ER  -

APA

M, Y., K, L., J, X., Y, L., L, J., & S, Z. (2026). KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers.. Molecular cancer. https://doi.org/10.1186/s12943-026-02659-w

Source records

pubmed · retrieved 2026-09-26T03:55:25.359Z